Intranasally delivered siRNA targeting PI3K/Akt/mTOR inflammatory pathways protects from aspergillosis.
Bonifazi P, D'Angelo C, Zagarella S, Zelante T, Bozza S, De Luca A, Giovannini G, Moretti S, Iannitti RG, Fallarino F, Carvalho A, Cunha C, Bistoni F, Romani L.
Bonifazi P, et al. Among authors: bistoni f.
Mucosal Immunol. 2010 Mar;3(2):193-205. doi: 10.1038/mi.2009.130. Epub 2009 Nov 18.
Mucosal Immunol. 2010.
PMID: 19924119
Free article.